Overactive bladder (OAB) is a condition that affects an estimated 33 million Americans. At least 16% of the population over the age of 40 is affected by the chronic symptoms of OAB.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.